Developing new treatments for antibiotic-resistant infections and emerging diseases
Official title: Development of Therapeutic Products for Biodefense, AntiMicrobial Resistant (AMR) Infections and Emerging Infectious Diseases
Funded at Crestone, INC. · NIH-11161135 · Data updated 2026-11-12
This study is working on new treatments to help people with infections that don't respond to regular antibiotics, so if you're struggling with tough-to-treat bacteria, this research could lead to better options for you in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Crestone, INC. NIH-funded |
| Lab location | 1 site (Boulder, United States) |
| Project start | September 9, 2019 |
| Project end | January 31, 2026 |
| Funding year | 2024 |
| Award (this year) | $4,595,632 |
| NIH project number | 75N93019C00056-P00011-9999-1 |
| Project ID | NIH-11161135 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit are individuals with infections caused by antibiotic-resistant bacteria or those at risk of emerging infectious diseases.
✕Less likely to help
Patients with infections that are not caused by antibiotic-resistant bacteria or those who do not have emerging infectious diseases may not benefit from this research.
What this research studies
This research focuses on creating new therapeutic products to combat antibiotic-resistant infections and emerging infectious diseases. It involves a series of development activities, including optimizing drug candidates, conducting preclinical studies, and assessing safety and efficacy in clinical trials. Patients may benefit from innovative treatments that target resistant bacteria, particularly those that are difficult to treat with existing medications. The research aims to advance these products through rigorous testing and regulatory processes.
Why it matters
Potential benefit: If successful, this research could lead to effective new treatments for patients suffering from antibiotic-resistant infections.
How similar studies have gone: Previous research has shown promise in developing treatments for antibiotic-resistant infections, indicating that this approach has potential for success.
Where this research is happening
-
Crestone, INC.
Boulder, United States Active
Researchers
- Principal investigator: Oschner, Urs — Crestone, INC.
- Study coordinator: Oschner, Urs
Related research
Other NIH-funded projects on the same topics.
-
Creating new treatments for infections that resist antibiotics
This study is looking for new treatments to help fight infections from tough bacteria, like Clostridioides difficile, and if you're interested, you might have a chance to join a trial testing these new options to see if they're safe and work well.
-
Creating new treatments for antibiotic-resistant bacteria
This study is working on creating new treatments to help fight infections caused by antibiotic-resistant bacteria, so that patients can have better options for getting well.
-
Creating new treatments for antibiotic-resistant bacteria
This study is working on creating new treatments to help fight infections caused by tough bacteria that don't respond to regular antibiotics, so patients can have better options for getting better.
-
Creating new treatments for antibiotic-resistant infections
This study is working on a new treatment to help fight infections caused by antibiotic-resistant bacteria, which could give patients more options when current medicines don't work.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.